stars 1 stars 2 stars 3

Recombinetics is a biotechnology company that is changing the way swine models can meet the needs of preclinical drug development. Using proprietary gene editing, our goal is to have the right model for the right drug - from disease models, to humanizations, to reporter lines and beyond. Better data starts with better models.

Recombinetics Questions

The Recombinetics annual revenue was $25 million in 2026.

Justin Zenanko is the CFO of Recombinetics.

9 people are employed at Recombinetics.

Recombinetics is based in New Brighton, Minnesota.

The NAICS codes for Recombinetics are [54, 541, 5417, 54171, 541714].

The SIC codes for Recombinetics are [873, 87].

Top Recombinetics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users